2020
DOI: 10.21608/jmr.2020.34439.1029
|View full text |Cite
|
Sign up to set email alerts
|

The possible protective effect of captopril on liver and bone marrow after cyclophosphamide-induced toxicity in adult albino rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 21 publications
0
1
0
Order By: Relevance
“…Angiotension-converting enzyme inhibitor captopril (CPL) is frequently administered to treat hypertension and congestive heart failure. The beneficial effect of CPL might be through the antioxidant mechanisms, which are reportedly correlated to the drug's sulfhydryl group (SH) that directly scavenges ROS 13 . Besides, CPL increases the antioxidant enzymes and nonenzymatic antioxidant defenses 14 .…”
Section: Introductionmentioning
confidence: 99%
“…Angiotension-converting enzyme inhibitor captopril (CPL) is frequently administered to treat hypertension and congestive heart failure. The beneficial effect of CPL might be through the antioxidant mechanisms, which are reportedly correlated to the drug's sulfhydryl group (SH) that directly scavenges ROS 13 . Besides, CPL increases the antioxidant enzymes and nonenzymatic antioxidant defenses 14 .…”
Section: Introductionmentioning
confidence: 99%
“…The sulfhydryl (SH) group in CAP's structure protects tissue from harm caused by oxidative stress and inflammation in many experimental models [11]. Moreover, CAP can boost the activity of antioxidant enzymes like superoxide dismutase (SOD) and glutathione peroxidase (GPx) [3,41]. CAP also lowers Ca + 2 levels by suppressing Ca + 2 transit through the cell membrane, preventing intracellular Ca + 2 overload and hence cell damage [2].…”
Section: Introductionmentioning
confidence: 99%